IP Library Granted Patent US 7,053,167
Granted Patent B2
US 7,053,167 · App. 10/661,536 · Granted May 30, 2006

Silsesquioxane derivative having functional group

Assignee: Chisso Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,053,167
App. No.
10/661,536
Granted
May 30, 2006
Kind
B2
Abstract

A conventional silsesquioxane derivative has the problems that the functional groups are restricted and the chemical structure is not readily controlled and that it is expensive. The present inventors have developed a process for producing a silsesquioxane derivative at a high yield by a simple process in order to solve such problems. The novel silsesquioxane derivative according to the present invention is controlled in a structure thereof and has a functional group, which is excellent in reactivity with a target compound, to be modified. The present invention relates to a production process for a silsesquioxane derivative represented by Formula (2), characterized by using a silicon compound represented by Formula (1). In Formula (1) and Formula (2), R is a group selected from hydrogen, alkyl, aryl and arylalkyl; M is a monovalent alkaline metal atom; at least one of Y is a group represented by Formula (3), and the remainder of Y is hydrogen; R 1 and R 2 in Formula (3) represent the same group as defined for R; and Z is a functional group or a group having a functional group

Claims (13)

1. A compound represented by Formula (1-2):

wherein F 3 is —CH 2 CH 2 CF 3 .

2. A compound represented by Formula (18):

wherein F 3 is —CH 2 CH 2 CF 3 , and Me is methyl.

3. A compound represented by Formula (19):

wherein F 3 is —CH 2 CH 2 CF 3 , and Me is methyl.

4. A compound represented by Formula (20):

wherein F 3 is —CH 2 CH 2 CF 3 , and Me is methyl.

5. A compound represented by Formula (1-5):

wherein F 4 is —CH 2 CH 2 (CF 2 ) 5 CF 3 .

6. A silsesquioxane derivative represented by Formula (2):

wherein R is 3,3,3-trifluoropropyl or tridecafluoro-1,1,2,2-tetrahydrooctyl; each Y is a group selected independently from groups represented by Formula (3) and hydrogen; and at least one of Y is a group selected from the groups represented by Formula (3):

wherein R 1 and R 2 represent independently methyl, isopropyl, tert-butyl or phenyl; Z is hydrogen, alkenyl, or a group having any of —OH, alkenyl, cycloalkenyl, —COOH, —COO—, —OCO—, 2-oxapropanedioyl, polyalkyleneoxy, acryloyloxy, methacryloyloxy, oxiranyl,3,4-epoxycyclohexyl, oxetanyl, oxetanylene, —NH 2 , —CN and —SH; provided that Z is not any of a group having a dithiocarbamate group, a group having haloalkylphenyl and a group having an α-haloester group.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2011
From: CHISSO CORPORATION
To: JNC CORPORATION
Reel/Frame 026187/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2003
From: YOSHIDA, KAZUHIRO; ITO, KENYA; OIKAWA, HISAO; YAMAHIRO, MIKIO; MORIMOTO, YOSHITAKA; OHGUMA, KOJI; WATANABE, KENICHI; OOTAKE, NOBUMASA
To: CHISSO CORPORATION
Reel/Frame 014498/0161 →
Priority Claims (2)
JP 2002-268716 · Sep 13, 2002 · national
JP 2003-123678 · Apr 28, 2003 · national
Continuity (1)
Related Publication 20040068074A1 · Apr 8, 2004